Meddenovo Drug Design
Meddenovo is a drug design company specializing in AI-supported cyclic peptide therapeutics. Founded by academics with over 10 years of experience in drug design and biomolecular modeling, Meddenovo accelerates pharmaceutical R&D by using computational biochemistry techniques to increase efficiency and reduce drug discovery costs by up to 30%. Their proprietary technology platform combines AI and physical computational approaches, integrated with the largest database of cyclic peptide-like medicines, to design novel drug candidates. Meddenovo offers services including in silico testing of drug candidates, de novo drug design, and generation of peptide databases. The company targets research groups and pharmaceutical companies, aiming to unlock the potential of cyclic peptides to address diseases with unmet medical needs through scalable, high-tech solutions.
Meddenovo Drug Design
Meddenovo is a drug design company specializing in AI-supported cyclic peptide therapeutics. Founded by academics with over 10 years of experience in drug design and biomolecular modeling, Meddenovo accelerates pharmaceutical R&D by using computational biochemistry techniques to increase efficiency and reduce drug discovery costs by up to 30%. Their proprietary technology platform combines AI and physical computational approaches, integrated with the largest database of cyclic peptide-like medicines, to design novel drug candidates. Meddenovo offers services including in silico testing of drug candidates, de novo drug design, and generation of peptide databases. The company targets research groups and pharmaceutical companies, aiming to unlock the potential of cyclic peptides to address diseases with unmet medical needs through scalable, high-tech solutions.